Collaborative, minimally invasive approach between electrophysiologists and cardiac surgeons offers great promise for the treatment of non-paroxysmal atrial fibrillation SAN RAMON, Calif.--(BUSINESS ...
The first three patients have been enrolled in the European HISTORIC-AF staged hybrid ablation study, Estech announced Monday afternoon. Ten centers will participate in the study, which is expected to ...
Estech Completes Additional $8 Million Financing; Names Tony Remington as US Vice President of Sales
SAN RAMON, Calif.--(BUSINESS WIRE)--Endoscopic Technologies, Inc. (Estech™), a leading provider of cardiac surgery devices, announced today that it has completed $8 million in equity financing through ...
WEST CHESTER, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading Atrial Fibrillation (Afib) medical device provider, and Endoscopic Technologies, Inc. d/b/a Estech (“Estech”), today ...
AtriCure ($ATRC) is set to acquire California-based surgical ablation device maker Estech in a deal worth at least $34 million and almost double that amount overall ...
, a leading Atrial Fibrillation (Afib) medical device provider, and Endoscopic Technologies, Inc. d/b/a Estech (“Estech”), today announced that they have entered into a definitive merger agreement ...
Estech, a leader in minimally invasive cardiac surgery, announced today that the first three patients have been enrolled in the HISTORIC-AF European multi-center staged hybrid ablation clinical study.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results